Orange you glad you ate that? study tests fruit against fatty liver
NCT ID NCT05558592
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether eating 400 grams of fresh oranges daily for a month could improve metabolism in 60 adults with metabolic-associated fatty liver disease (MAFLD). Participants either ate oranges or other fruits. Researchers measured changes in liver fat and blood fats. The goal was to see if oranges could help control the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- oranges (Navelina variety)
- What this could lead to
- If it works, this could point toward a simple dietary addition to help manage fatty liver disease and reduce metabolic risk.
- What could go wrong
- This is a small, completed study with only 60 participants. The results may not apply to everyone, and dietary changes alone may not be enough for significant improvement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FATTY LIVER, NONALCOHOLIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IRCCS Saverio de Bellis
Castellana Grotte, BARI, 70013, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Wearable sensor may replace the dreaded glucose drink test for gestational diabetes
- Fixing sleep, fortifying hearts: a new trial tests the link
- Can a Pre-Pregnancy lifestyle program boost mother and child health?
- Wearable tech could stop Post-Pregnancy diabetes in its tracks
- Heart hormone boost may cut diabetes risk in black individuals — a trial puts it to the test
- Eating within a 10-hour window may shield breast cancer patients from heart-harming fat buildup